MedPath

JAPAN CLINICAL CANCER RESEARCH ORGANIZATION

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website
http://www.jaccro.com/

Clinical Trials

23

Active:0
Completed:21

Trial Phases

4 Phases

Phase 1:4
Phase 2:9
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials

Phase 2
9 (39.1%)
Not Applicable
8 (34.8%)
Phase 1
4 (17.4%)
Phase 3
2 (8.7%)

A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

Phase 2
Conditions
Colorectal Cancer
Interventions
First Posted Date
2015-08-05
Last Posted Date
2015-08-05
Lead Sponsor
Japan Clinical Cancer Research Organization
Target Recruit Count
360
Registration Number
NCT02515734

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

Phase 1
Conditions
Rectal Carcinoma
Interventions
Radiation: Radiation
First Posted Date
2010-10-25
Last Posted Date
2012-11-27
Lead Sponsor
Japan Clinical Cancer Research Organization
Target Recruit Count
45
Registration Number
NCT01227239
Locations
🇯🇵

Nagoya University Graduate School of Medicine, Nagoya, Japan

🇯🇵

Osaka Medical College, Osaka, Japan

🇯🇵

Jichi Medical University Hospital, Tochigi, Japan

and more 3 locations

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Phase 2
Completed
Conditions
Gastric Cancer
Interventions
First Posted Date
2008-03-20
Last Posted Date
2011-06-28
Lead Sponsor
Japan Clinical Cancer Research Organization
Target Recruit Count
300
Registration Number
NCT00639327
Locations
🇯🇵

Midori Municipal Hospital, Nagoya, Aichi, Japan

🇯🇵

Nagoya City University Hospital, Nagoya, Aichi, Japan

🇯🇵

Yamamoto Hospital, Noshiro, Akita, Japan

and more 83 locations

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2007-08-09
Last Posted Date
2011-06-28
Lead Sponsor
Japan Clinical Cancer Research Organization
Target Recruit Count
110
Registration Number
NCT00514163
Locations
🇯🇵

Cancer Institute Ariake Hospital, Tokyo, Japan

Clinical Trial of Chemosensitivity Test

Phase 2
Completed
Conditions
Gastric Cancer
Interventions
First Posted Date
2006-02-07
Last Posted Date
2011-06-29
Lead Sponsor
Japan Clinical Cancer Research Organization
Target Recruit Count
300
Registration Number
NCT00287755
Locations
🇯🇵

Nagoya University Hospital, Nagoya, Aichi, Japan

🇯🇵

Gunma University Hospital, Maehashi, Gunma, Japan

🇯🇵

Hakodate Goryoukaku Hopsital, Hakodate, Hokkaido, Japan

and more 33 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.